Document is current
Any future updates will be listed below
-
Authors
Tikiso, Tjokosela
Fuhrmann, Valentin
König, Christina
Jarczak, Dominik
Iwersen-Bergmann, Stefanie
Kluge, Stefan
Wicha, Sebastian G.
Grensemann, Jörn https://orcid.org/0000-0002-3341-669X
-
Funding
Funding for this research was provided by:
Damp Stiftung (2017-20)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 25 May 2023
Accepted: 1 September 2023
First Online: 12 September 2023
Declarations
:
: The study was approved by the Ethics Committee of the Hamburg Chamber of Physicians, Germany (Reference: PV5415). Consent was obtained from the patients’ closest relatives or legal surrogates. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
: SK received research support from Cytosorbents and Daiichi Sankyo, lecture fees from Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer and Zoll, and consultant fees from Fresenius, Gilead, MSD and Pfizer. SGW reports grants from Boehringer Ingelheim, consulting fees from Medicines for Malaria Venture, Merck KGaA, UTIlity Therapeutics, and lecture fees from GlaxoSmithKline. JG received research support and lecture fees from Infectopharm, and research support from Pfizer outside of the presented work. CK reports lecture fees from Gilead and Shionogi as well as research support from Infectopharm.
